Analytical Data
-
Gene name
CD164L2
- Application
-
Alternative Names
CD164L2；CD164 sialomucin-like 2 Protein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6UWJ8-2
-
Expression Region
30-141aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSGKGARGF GRGALIRLNI WPAVQGACKQ LEVCEHCVEG DRARNLSSCM WEQCRPEEPG HCVAQSEVVK EGCSIYNRSE ACPAAHHHPT YEPKTVTTGS PPVPEAHSPG FDGAS
-
Molecular Weight
14 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CD164L2, a member of the CD164 family of proteins, has garnered attention in immunology and cell biology due to its role in hematopoiesis and immune regulation. This protein is primarily expressed in various immune cells and is believed to influence cell adhesion, migration, and differentiation. Research indicates that CD164L2 may be involved in the regulation of T-cell responses and antigen presentation, making it a potential target for therapeutic strategies in autoimmune diseases and cancer. The study of CD164L2 recombinant protein has enabled scientists to investigate its functional properties and interaction with other molecular players in the immune system. By generating and characterizing this recombinant protein, researchers aim to elucidate its precise role in immune mechanisms and to explore its potential applications in immunotherapy. Understanding the biochemical pathways involving CD164L2 can provide insights into novel treatment modalities that harness immune responses, thereby contributing to the advancement of personalized medicine approaches. This underscores the importance of CD164L2 in both basic research and clinical applications, highlighting its significance in understanding complex immune processes.
